Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Nov 1;4(6):1495-503.
doi: 10.1177/193229681000400625.

Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit

Anna Chang  1 , Joy Frank, Jennifer Knaebel, Jeanellen Fullam, Scott Pardo, David A Simmons
Affiliations
Clinical Trial

Evaluation of an over-the-counter glycated hemoglobin (A1C) test kit

Anna Chang et al. J Diabetes Sci Technol. .

Abstract

Background: Glycated hemoglobin (A1C) monitoring is an integral component of diabetes management. This study was conducted to evaluate the performance of the A1CNow® SELFCHECK device when used by lay users and health care professionals (HCPs) to measure A1C.

Methods: Subjects performed two A1CNow SELFCHECK finger-stick self-tests followed by a finger-stick test of the subject's blood by a HCP. The primary endpoint assessed accuracy of the subject and HCP A1CNow SELFCHECK readings. Secondary endpoints included precision, comprehension of instructional material (written material±DVD), and product satisfaction. For accuracy comparison, a venous blood sample was drawn from each subject and tested by laboratory (TOSOH) analysis. Subject comprehension of product instructional material was evaluated via first-time failure (FTF) rate as recorded by the HCP, and subject satisfaction was assessed through written survey.

Results: A total of 110 subjects with (n=93) and without (n=17) diabetes participated. Of 177 subject A1C values, 165 (93.2%) were within the acceptable range of ±13.5% of the laboratory reference value and considered accurate. Regression analysis showed good correlation of subject values to laboratory and HCP results (R2=0.93 for both). The average within-subject coefficient of variation was 4.57% (n=74). The FTF rates with and without instructional DVD were 11.3% (n=56) and 39.6% (n=54), respectively. Subjects with diabetes/prediabetes overwhelmingly indicated that they were "very" to "extremely" likely (93.5%) to discuss their home A1C results with their HCP.

Conclusions: Lay users found the A1CNow SELFCHECK easy to use, and both lay users and HCPs were able to measure A1C accurately.

PubMed Disclaimer

Figures

Figure 2
Figure 2
Bland–Altman plot of subject readings compared with the TOSOH method.
Figure 1
Figure 1
Regression analysis of subject and HCP readings: subject readings compared with TOSOH method (A), HCP readings compared with TOSOH method (B), and subject readings compared with HCP readings (C). Solid lines are lines of regression from the corresponding equation in each panel, and dotted lines are lines of identity (y = x).
Figure 3
Figure 3
Subject FTF rates.
Figure 4
Figure 4
Feature survey results.
Figure 5
Figure 5
Clarity of instructional material.
Figure 6
Figure 6
Survey results of subjects with diabetes (n = 93). How likely would subjects be to discuss the results of an at-home A1C test with their doctor or HCP? (A) Assuming subjects had this product, how would it impact how often they test their own blood sugar/glucose levels? (B)
See this image and copyright information in PMC

Comment in

References

    1. Centers for Disease Control and Prevention . National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.
    1. American Diabetes Association Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Suppl 1):S11–S61. - PMC - PubMed
    1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. - PubMed
    1. Saudek CD, Brick JC. The clinical use of hemoglobin A1c. J Diabetes Sci Technol. 2009;3(4):629–634. - PMC - PubMed
    1. Crivera C, Suh DC, Huang ES, Cagliero E, Grant RW, Vo L, Shin HC, Meigs JB. The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients. Curr Med Res Opin. 2006;22(11):2301–2311. - PMC - PubMed

Publication types

MeSH terms